These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 25898815

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
    Giorgadze T, Rossi ED, Fadda G, Gupta PK, Livolsi VA, Baloch Z.
    Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
    [Abstract] [Full Text] [Related]

  • 3. High Grade Differentiated Follicular Cell-Derived Thyroid Carcinoma Versus Poorly Differentiated Thyroid Carcinoma: A Clinicopathologic Analysis of 41 Cases.
    Thompson LDR.
    Endocr Pathol; 2023 Jun; 34(2):234-246. PubMed ID: 37195480
    [Abstract] [Full Text] [Related]

  • 4. The Oncocytic Variant of Poorly Differentiated Thyroid Carcinoma Shows a Specific Immune-Related Gene Expression Profile.
    Metovic J, Vignale C, Annaratone L, Osella-Abate S, Maletta F, Rapa I, Cabutti F, Patriarca S, Gallo M, Nikiforov YE, Volante M, Papotti M.
    J Clin Endocrinol Metab; 2020 Dec 01; 105(12):. PubMed ID: 32936917
    [Abstract] [Full Text] [Related]

  • 5. DICER1 Mutations Do Not Always Indicate Dismal Prognosis in Pediatric Poorly Differentiated Thyroid Carcinomas.
    Yegen G, Altay AY, Yılmaz İ, İşcan Y, Sormaz İC, Aksakal N, Önder S, Mete Ö.
    Endocr Pathol; 2023 Sep 01; 34(3):279-286. PubMed ID: 37574466
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
    Xu B, Ibrahimpasic T, Wang L, Sabra MM, Migliacci JC, Tuttle RM, Ganly I, Ghossein R.
    Thyroid; 2016 Nov 01; 26(11):1588-1597. PubMed ID: 27480016
    [Abstract] [Full Text] [Related]

  • 8. Follicular and Hurthle cell carcinomas of the thyroid: a comparative study.
    Evans HL, Vassilopoulou-Sellin R.
    Am J Surg Pathol; 1998 Dec 01; 22(12):1512-20. PubMed ID: 9850177
    [Abstract] [Full Text] [Related]

  • 9. Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma.
    Wong KS, Lorch JH, Alexander EK, Marqusee E, Cho NL, Nehs MA, Doherty GM, Barletta JA.
    Thyroid; 2019 Sep 01; 29(9):1255-1261. PubMed ID: 31397224
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Significance of oncocytic features in poorly differentiated thyroid carcinoma - a bi-institutional experience.
    Xu B, Lubin DJ, Dogan S, Ghossein RA, Viswanathan K.
    Virchows Arch; 2023 Mar 01; 482(3):479-491. PubMed ID: 36346459
    [Abstract] [Full Text] [Related]

  • 12. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
    Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, LiVolsi VA, Papotti MG, Sobrinho-Simões M, Tallini G, Mete O.
    Endocr Pathol; 2022 Mar 01; 33(1):27-63. PubMed ID: 35288841
    [Abstract] [Full Text] [Related]

  • 13. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D, Carlson DL, Tuttle RM, Chuai S, Ishill N, Shaha A, Shah JP, Singh B, Ghossein RA.
    Cancer; 2006 Mar 15; 106(6):1286-95. PubMed ID: 16470605
    [Abstract] [Full Text] [Related]

  • 14. PTEN and TP53 Mutations in Oncocytic Follicular Carcinoma.
    Wei S, LiVolsi VA, Montone KT, Morrissette JJ, Baloch ZW.
    Endocr Pathol; 2015 Dec 15; 26(4):365-9. PubMed ID: 26530486
    [Abstract] [Full Text] [Related]

  • 15. Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases.
    Ghossein RA, Hiltzik DH, Carlson DL, Patel S, Shaha A, Shah JP, Tuttle RM, Singh B.
    Cancer; 2006 Apr 15; 106(8):1669-76. PubMed ID: 16534796
    [Abstract] [Full Text] [Related]

  • 16. Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma?
    Sugino K, Kameyama K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Akaishi J, Suzuki A, Masaki C, Ito K.
    Ann Surg Oncol; 2013 Sep 15; 20(9):2944-50. PubMed ID: 23616135
    [Abstract] [Full Text] [Related]

  • 17. Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data.
    Kim WG, Kim TY, Kim TH, Jang HW, Jo YS, Park YJ, Kim SW, Kim WB, Shong M, Park DJ, Chung JH, Shong YK, Cho BY.
    Korean J Intern Med; 2014 May 15; 29(3):325-33. PubMed ID: 24851067
    [Abstract] [Full Text] [Related]

  • 18. Re-evaluation of histopathological factors affecting prognosis of differentiated thyroid carcinoma in an iodine-sufficient country.
    Sugitani I, Toda K, Yamamoto N, Sakamoto A, Fujimoto Y.
    World J Surg; 2010 Jun 15; 34(6):1265-73. PubMed ID: 19953247
    [Abstract] [Full Text] [Related]

  • 19. Oncocytic Follicular Cell-Derived Thyroid Tumors With Papillary Growth Pattern: A Clinicopathologic Study of 32 Cases.
    Suster D, Ronen N, Giorgadze T, Baisre-de Leon A, Montalvan I, Suster S.
    Arch Pathol Lab Med; 2024 Sep 01; 148(9):997-1006. PubMed ID: 38100177
    [Abstract] [Full Text] [Related]

  • 20. Poorly differentiated oncocytic thyroid carcinoma--diagnostic implications and outcome.
    Dettmer M, Schmitt A, Steinert H, Moch H, Komminoth P, Perren A.
    Histopathology; 2012 Jun 01; 60(7):1045-51. PubMed ID: 22348590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.